PRESS DIGEST- Financial Times - May 15
May 15 (Reuters) - Following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Headlines
- EU rebuffs UK attempt to continue collaborating on nuclear fusion experiment
- OpenAI co-founder and chief scientist Ilya Sutskever departs
- Novo Nordisk to test weight-loss drugs' effect on alcohol use and liver disease
- HMRC customer service 'in declining spiral', says UK spending watchdog
Overview
- Britain's attempt to continue collaborating in the world's largest nuclear fusion experiment has been rebuffed by the EU, which wants Britain to rejoin its civil atomic programme as part of the deal.
- OpenAI co-founder and chief scientist Ilya Sutskever is leaving the startup at the center of today's artificial intelligence boom.
- Novo Nordisk is trialling its weight-loss drugs to explore if they can reduce alcohol intake and treat alcoholic liver disease, as it seeks to expand the uses of the blockbuster treatments.
- Britain's HM Revenue & Customs' customer service is "in a declining spiral", according to a report by the UK public spending watchdog, which found taxpayers spent the equivalent of 800 years on hold to the agency in 2022-23.
(Compiled by Bengaluru newsroom)